Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion
Anticancer Research · 2023
DOI: 10.21873/anticanres.16577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von DA Yeon Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Killer Cells, Natural. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
- College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
- Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea.
- Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; chpark@krict.re.kr.
Zitieren
APA
Lee, D. Y., Kim, Y., Park, J. S., Choi, J. U., Jeong, H. G., & Park, C. H. (2023). Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion. Anticancer Research. https://doi.org/10.21873/anticanres.16577
Vancouver
Lee DY, Kim Y, Park JS, Choi JU, Jeong HG, Park CH. Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion. Anticancer Research. 2023. doi:10.21873/anticanres.16577
BibTeX
@article{Lee2023,
author = {Lee, DA Yeon and Kim, Yeongrin and Park, Jin Song and Choi, Ji U and Jeong, Hye Gwang and Park, Chi Hoon},
title = {Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16577}
}
EUVIMED